SCHEMBL324789

SCHEMBL324789

Cc1ccc(CCC(=O)O)c(C)c1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.68
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
FFAR1 O14842 6/20 0.49
FFAR4 Q5NUL3 3/20 0.49
TSHR P16473 1/20 0.49
POLB P06746 1/20 0.47
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
RXRG P48443 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SRC P12931 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
PTGER1 P34995 1/20 0.46
PTGER4 P35408 1/20 0.46
PTGER3 P43115 1/20 0.46
PTGER2 P43116 1/20 0.46
EGFR P00533 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31689801 1.00 NPSR1 (0.68) NPSR1MEN1KMT2AFFAR1FFAR4
SCHEMBL1454248 0.91 TSHR (0.56) NPSR1MEN1KMT2AFFAR1TSHR
SCHEMBL6207355 0.87 F13A1 (0.53) NPSR1MEN1KMT2ATSHRNPC1
SCHEMBL27927872 0.86 NPSR1 (0.48) NPSR1MEN1KMT2ATSHRNPC1
SCHEMBL11286813 0.86 F13A1 (0.56) NPSR1MEN1KMT2ATSHR
SCHEMBL3925297 0.86 F13A1 (0.56) NPSR1MEN1KMT2ATSHR
SCHEMBL29636581 0.85 NPSR1 (0.68) NPSR1MEN1KMT2AFFAR1FFAR4
SCHEMBL3670598 0.85 NPSR1 (0.68) NPSR1MEN1KMT2AFFAR1FFAR4
SCHEMBL8186371 0.85 NPSR1 (0.47) NPSR1MEN1KMT2ATSHRPOLB
SCHEMBL14110381 0.83 NPSR1 (0.55) NPSR1MEN1KMT2AFFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3688124-A1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME ExxonMobil Chemical Patents Inc. (US) 2020-08-05 EP claimed
US-10711216-B2 Ester compounds, lubricating oil compositions containing same and processes for making same EXXONMOBIL CHEMICAL PATENTS INC. (US) 2020-07-14 US claimed
US-20190100710-A1 Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same EXXONMOBIL CHEMICAL PATENTS INC. 2019-04-04 US claimed
WO-2019067061-A1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME EXXONMOBIL CHEMICAL PATENTS INC. (US) 2019-04-04 WO claimed
EP-3397738-A1 HIGH VISCOSITY INDEX MONOMETHYL ESTER LUBRICATING OIL BASE STOCKS AND METHODS OF MAKING AND USE THEREOF ExxonMobil Research and Engineering Company (US) 2018-11-07 EP claimed
US-20180119045-A1 HIGH VISCOSITY INDEX MONOMETHYL ESTER LUBRICATING OIL BASE STOCKS AND METHODS OF MAKING AND USE THEREOF EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2018-05-03 US claimed
WO-2017116900-A1 HIGH VISCOSITY INDEX MONOMETHYL ESTER LUBRICATING OIL BASE STOCKS AND METHODS OF MAKING AND USE THEREOF EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2017-07-06 WO claimed
EP-3688124-B1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-10-25 EP disclosed
US-11253596-B2 Phenylalkylcarboxylic acid delivery agents NOVO NORDISK NORTH AMERICA OPERATIONS A/S (DK) 2022-02-22 US disclosed
US-20200405863-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS NOVO NORDISK A/S (DK) 2020-12-31 US disclosed
EP-3688124-A1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME ExxonMobil Chemical Patents Inc. (US) 2020-08-05 EP disclosed
US-10711216-B2 Ester compounds, lubricating oil compositions containing same and processes for making same EXXONMOBIL CHEMICAL PATENTS INC. (US) 2020-07-14 US disclosed
US-10456472-B2 Phenylalkylcarboxylic acid delivery agents EMISPHERE TECHNOLOGIES, INC. (US) 2019-10-29 US disclosed
US-6716840-B2 AGONISTS OF THE MELANOCORTIN-4 RECEPTOR (?MC-4R?); USEFUL TREATING OBESITY AND TYPE 2 DIABETES CHIRON CORPORATION 2004-04-06 US disclosed
US-20040024211-A1 Novel guanidino compounds CHIRON CORPORATION 2004-02-05 US disclosed
EP-1385823-A1 NOVEL GUANIDINO COMPOUNDS CHIRON CORPORATION (US) 2004-02-04 EP disclosed
US-20030195187-A1 Guanidino compounds CHIRON CORPORATION 2003-10-16 US disclosed
WO-2003066597-A2 GUANIDINO COMPOUNDS CHIRON CORPORATION (US) 2003-08-14 WO disclosed
US-20020193595-A1 Novel guanidino compounds CHU DANIEL (US) 2002-12-19 US disclosed
WO-2002081443-A1 NOVEL GUANIDINO COMPOUNDS CHIRON CORPORATION (US) 2002-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200405863-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS PGF, LIPA, PDGFA NPSR1 1464/4885MEN1 4664/4885KMT2A 3858/4885
US-20030195187-A1 Guanidino compounds MC4R, MC2R, GPR4 NPSR1 399/4885MEN1 478/4885KMT2A 3202/4885
US-20040024211-A1 Novel guanidino compounds MC4R, MC5R, MC3R NPSR1 117/4885MEN1 2880/4885KMT2A 3056/4885
US-10456472-B2 Phenylalkylcarboxylic acid delivery agents PGF, LIPA, PDGFA NPSR1 1464/4885MEN1 4664/4885KMT2A 3858/4885
US-20020193595-A1 Novel guanidino compounds MC4R, MC5R, MC3R NPSR1 140/4885MEN1 2491/4885KMT2A 2883/4885
US-10711216-B2 Ester compounds, lubricating oil compositions containing same and processes for making same ELOVL1, NOTUM, ELOVL5 NPSR1 2635/4885MEN1 3176/4885KMT2A 4001/4885
US-11253596-B2 Phenylalkylcarboxylic acid delivery agents PGF, LIPA, PDGFA NPSR1 1464/4885MEN1 4664/4885KMT2A 3858/4885
US-20190100710-A1 Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same ELOVL1, NOTUM, ELOVL5 NPSR1 2635/4885MEN1 3176/4885KMT2A 4001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.